pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
mechlorethamine hydrochloride
Valchlor (mechlorethamine hydrochloride)
Mycosis Fungoides
Helsinn Therapeutics (US) Inc
Marketed
meclofenamate sodium
Meclofenamate Sodium
Acute and Sub-Acute Bursitis
Mylan Pharmaceuticals Inc
Marketed
medroxyprogesterone
Medroxyprogesterone Acetate (medroxyprogesterone [INN])
Female Contraception
Xiromed LLC
Marketed
← prev
page 229 of 271
next →
Pain
89
Neurology
1
mefloquine hydrochloride
Mefloquine Hydrochloride
Malaria
Barr Laboratories Inc
Marketed
megestrol acetate
Megestrol Acetate
Anorexia Nervosa
TWi Pharmaceuticals USA Inc
Marketed
meloxicam
Qamzova (meloxicam)
Post-Operative Pain
Nanjing Delova Biotech Co Ltd
Preclinical
meloxicam SR
meloxicam
Pain
Cali Biosciences Co Ltd
Marketed
melphalan
Evomela (melphalan)
Retinoblastoma
Zhaoke Ophthalmology Ltd
Marketed
melphalan hydrochloride
Melblez (melphalan hydrochloride)
Bile Duct Cancer (Cholangiocarcinoma)
$DCTH
DELCATH SYSTEMS, INC.
Marketed
memantine hydrochloride
Memantine Hydrochloride
Dementia Associated With Alzheimer's Disease
Polygen Pharmaceuticals Inc
Marketed
memantine hydrochloride ER
Memantine Hydrochloride
Dementia Associated With Alzheimer's Disease
Vitruvias Therapeutics LLC
Phase 2
meningococcal (pentavalent) vaccine
MenPenta
Neisseria meningitidis Infections
$SNY
Sanofi
Phase 3
meningococcal [serotype B] vaccine
Bexsero
Neisseria meningitidis Infections
$GSK
GSK plc
Marketed
meningococcal [serotype C] vaccine
Menomune-C
Neisseria meningitidis Infections
Sanofi Pasteur Inc
Marketed
meningococcal [serotypes A, B, C, W-135, Y] vaccine
Penmenvy
Neisseria meningitidis Infections
GlaxoSmithKline LLC
Marketed
meningococcal [serotypes A, C, W-135, Y] vaccine
Menveo
Neisseria meningitidis Infections
GlaxoSmithKline LLC
Marketed
meningococcal [serotypes A, C, W-135, Y] vaccine (Menactra)
Menactra
Neisseria meningitidis Infections
Sanofi Pasteur Inc
Phase 3
menotropins
menotropins
Female Infertility
Granata Bio Inc
Preclinical
mepacrine
mepacrine [INN]
Pulmonary Arterial Hypertension
PulmoSIM Therapeutics Inc
Marketed
mepenzolate bromide
Cantil (mepenzolate bromide [INN])
Peptic Ulcers
Sanofi-Aventis US LLC
Marketed
mepivacaine hydrochloride
Polocaine (mepivacaine hydrochloride)
Local Anesthetic Effect
Fresenius Kabi USA LLC
Phase 2
meplazumab
Ketantin
Malaria
Jiangsu Pacific Meinuoke Bio-Pharmarceutical Co Ltd
Marketed
mepolizumab
Nucala (mepolizumab)
Eosinophilic Granulomatosis with Polyangiitis (Churg-Stra…
GlaxoSmithKline LLC
Marketed
meprobamate
Meprobamate
Anxiety Disorders
InvaGen Pharmaceuticals Inc
Marketed
mercaptopurine
Purixan (mercaptopurine)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Rare Disease Therapeutics Inc
Phase 1
meropenem + pilabactam
meropenem [INN] + pilabactam [INN]
Acinetobacter Infections
Antabio SAS
Marketed
mesalamine
Canasa (mesalamine)
Proctitis
$ABBV
AbbVie Inc.
Marketed
mesalamine DR
Mesalamine
Ulcerative Colitis
Sinotherapeutics Inc
Marketed
mesalamine ER
Mesalamine Lupin (mesalamine)
Ulcerative Colitis
Lupin Ltd
Marketed
mesalamine PR
Pentasa (mesalamine)
Ulcerative Colitis
Takeda Pharmaceuticals USA Inc
